Supplementary Table S5 from Neoantigen Targetability in Progressive Advanced Melanoma

Supplementary Table S5 from Neoantigen Targetability in Progressive Advanced Melanoma

<p>Eluted tumor-associated antigen-derived peptides.</p>

সংরক্ষণ করুন:

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক:	Jitske van den Bulk (17142147) (author)
অন্যান্য লেখক:	Els M.E. Verdegaal (17142150) (author), Manon van der Ploeg (17142153) (author), Marten Visser (17142156) (author), Joana B. Nunes (17142159) (author), Arnoud H. de Ru (17142162) (author), Rayman T.N. Tjokrodirijo (17142165) (author), Marieke E. Ijsselsteijn (17142168) (author), Natasja I. Janssen (17142171) (author), Ruud van der Breggen (17142174) (author), Linda de Bruin (17142177) (author), Pita de Kok (17142180) (author), George M.C. Janssen (17142183) (author), Dina Ruano (17142186) (author), Ellen H.W. Kapiteijn (17142189) (author), Peter A. van Veelen (17142192) (author), Noel F.C.C. de Miranda (17142195) (author), Sjoerd H. van der Burg (15021483) (author)
প্রকাশিত:	2025
বিষয়গুলি:	Cancer Immuno-oncology Immunology Tumor antigens/neoantigens Immunotherapy Cellular immunotherapy Skin Cancers Melanoma
ট্যাগগুলো:	ট্যাগ যুক্ত করুন কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!

অনুরূপ উপাদানগুলি

Supplementary Table S1 from Neoantigen Targetability in Progressive Advanced Melanoma
অনুযায়ী: Jitske van den Bulk (17142147)
প্রকাশিত: (2025)

Supplementary Table S2 from Neoantigen Targetability in Progressive Advanced Melanoma
অনুযায়ী: Jitske van den Bulk (17142147)
প্রকাশিত: (2025)

Supplementary Table S3 from Neoantigen Targetability in Progressive Advanced Melanoma
অনুযায়ী: Jitske van den Bulk (17142147)
প্রকাশিত: (2025)

Supplementary Table S4 from Neoantigen Targetability in Progressive Advanced Melanoma
অনুযায়ী: Jitske van den Bulk (17142147)
প্রকাশিত: (2025)

Figure S1 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
অনুযায়ী: Michael Kilian (16697663)
প্রকাশিত: (2025)

Figure S2 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
অনুযায়ী: Michael Kilian (16697663)
প্রকাশিত: (2025)

Figure S3 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
অনুযায়ী: Michael Kilian (16697663)
প্রকাশিত: (2025)

Supplementary Data S1 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
অনুযায়ী: Maria Lozano-Rabella (15056515)
প্রকাশিত: (2025)

Supplementary Data S2 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
অনুযায়ী: Maria Lozano-Rabella (15056515)
প্রকাশিত: (2025)

Supplementary Data S3 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
অনুযায়ী: Maria Lozano-Rabella (15056515)
প্রকাশিত: (2025)

Supplementary Table 1 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
অনুযায়ী: Caroline Robert (15032672)
প্রকাশিত: (2025)

Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
অনুযায়ী: Caroline Robert (15032672)
প্রকাশিত: (2025)

Supplementary Table 3 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
অনুযায়ী: Caroline Robert (15032672)
প্রকাশিত: (2025)

Supplementary Table 4 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
অনুযায়ী: Caroline Robert (15032672)
প্রকাশিত: (2025)

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
অনুযায়ী: Hansol Lee (15054787)
প্রকাশিত: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
অনুযায়ী: Hansol Lee (15054787)
প্রকাশিত: (2025)

Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
অনুযায়ী: Hansol Lee (15054787)
প্রকাশিত: (2025)

Supplementary Table S4 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
অনুযায়ী: Hansol Lee (15054787)
প্রকাশিত: (2025)

Table S5 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
অনুযায়ী: Joseph Toker (15399882)
প্রকাশিত: (2025)

Table S2 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
অনুযায়ী: Joseph Toker (15399882)
প্রকাশিত: (2025)

Table S3 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
অনুযায়ী: Joseph Toker (15399882)
প্রকাশিত: (2025)

Table S4 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
অনুযায়ী: Joseph Toker (15399882)
প্রকাশিত: (2025)

Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
অনুযায়ী: Joseph Toker (15399882)
প্রকাশিত: (2025)

Table S7 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
অনুযায়ী: Joseph Toker (15399882)
প্রকাশিত: (2025)

Table S8 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
অনুযায়ী: Joseph Toker (15399882)
প্রকাশিত: (2025)

CD38CD39 Population DEGs DS1 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
অনুযায়ী: Ankita Mitra (17141783)
প্রকাশিত: (2025)

Teee Gene Signature DS2 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
অনুযায়ী: Ankita Mitra (17141783)
প্রকাশিত: (2025)

Teee vs Treg Clusters DEGs DS3 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
অনুযায়ী: Ankita Mitra (17141783)
প্রকাশিত: (2025)

Supplementary Table S5 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
অনুযায়ী: Christine Pich-Bavastro (16509238)
প্রকাশিত: (2025)

Supplementary Figure 5 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
অনুযায়ী: Wei Liu (20030)
প্রকাশিত: (2025)

Supplementary Table S1 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
অনুযায়ী: Christine Pich-Bavastro (16509238)
প্রকাশিত: (2025)

Supplementary Table S2 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
অনুযায়ী: Christine Pich-Bavastro (16509238)
প্রকাশিত: (2025)

Supplementary Table S3 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
অনুযায়ী: Christine Pich-Bavastro (16509238)
প্রকাশিত: (2025)

Supplementary Table S4 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
অনুযায়ী: Christine Pich-Bavastro (16509238)
প্রকাশিত: (2025)

Supplementary Table S6 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
অনুযায়ী: Christine Pich-Bavastro (16509238)
প্রকাশিত: (2025)

Supplementary Table S7 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
অনুযায়ী: Christine Pich-Bavastro (16509238)
প্রকাশিত: (2025)

Supplementary Figure S5 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
অনুযায়ী: Rohit Thummalapalli (17314483)
প্রকাশিত: (2025)

Supplementary Figure 1 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
অনুযায়ী: Wei Liu (20030)
প্রকাশিত: (2025)

Supplementary Figure 2 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
অনুযায়ী: Wei Liu (20030)
প্রকাশিত: (2025)

Supplementary Figure 3 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
অনুযায়ী: Wei Liu (20030)
প্রকাশিত: (2025)

Cannot write session to /tmp/vufind_sessions/sess_qu50atjsnebr8uf2m4aus0hnc6